An increasing number of adolescents and young adults are developing cancer, and they face unique challenges because the illness occurs during a crucial time of personal growth. It's vital that patients' care teams focus on their priorities for treatment and goals for survivorship.
As new CAR T-cell therapies are being approved to treat certain cancers, UT Southwestern explains how its team is working to further revolutionize treatment for more cancer patients.
The pediatric teams for AML therapy with KYMRIAH at UT Southwestern and Children’s Health explore how CAR T-cell technology can treat other cancers. Learn more.
